Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar;94(3):979-984.
doi: 10.1002/jmv.27404. Epub 2021 Oct 24.

Long COVID syndrome-associated brain fog

Affiliations

Long COVID syndrome-associated brain fog

Ali A Asadi-Pooya et al. J Med Virol. 2022 Mar.

Abstract

We investigated the frequency of brain fog in a large cohort of patients with documented coronavirus disease-2019 (COVID-19) who have survived the illness. We also scrutinized the potential risk factors associated with the development of brain fog. Adult patients (18-55 years of age), who were referred to the healthcare facilities anywhere in Fars province from February 19, 2020 to November 20, 2020 were included. All patients had a confirmed COVID-19 diagnosis. In a phone call, at least 3 months after their discharge from the hospital, we obtained their current information. A questionnaire was specifically designed for data collection. In total, 2696 patients had the inclusion criteria; 1680 (62.3%) people reported long COVID syndrome (LCS). LCS-associated brain fog was reported by 194 (7.2%) patients. Female sex (odds ratio [OR]: 1.4), respiratory problems at the onset (OR: 1.9), and intensive care unit (ICU) admission (OR: 1.7) were significantly associated with reporting chronic post-COVID "brain fog" by the patients. In this large population-based study, we report that chronic post-COVID "brain fog" has significant associations with sex (female), respiratory symptoms at the onset, and the severity of the illness (ICU admission).

Keywords: COVID-19; SARS-CoV-2; brain; coronavirus.

PubMed Disclaimer

Conflict of interest statement

Ali A. Asadi‐Pooya received honoraria from Cobel Daruo, RaymandRad, and Tekaje and Royalty from Oxford University Press (book publication). Other authors have no conflict of interests.

Figures

Figure 1
Figure 1
The recruitment process of the study

References

    1. Walitt B, Bartrum E. A clinical primer for the expected and potential post‐COVID‐19 syndromes. Pain Rep. 2021;6:e887. - PMC - PubMed
    1. Arnold DT, Hamilton FW, Milne A, et al. Patient outcomes after hospitalisation with COVID‐19 and implications for follow‐up: results from a prospective UK cohort. Thorax. 2021;76:399‐401. - PMC - PubMed
    1. Accessed June 18, 2021. https://www.nice.org.uk/guidance/ng188/
    1. Raveendran AV. Long COVID‐19: Challenges in the diagnosis and proposed diagnostic criteria. Diabetes Metab Syndr. 2021;15:145‐146. - PMC - PubMed
    1. Asadi‐Pooya AA, Simani L. Central nervous system manifestations of COVID‐19: a systematic review. J Neurol Sci. 2020;413:116832. - PMC - PubMed